A subsidiary of Sun Pharmaceutical Industries has received approval from the US Foods and Drugs Administration for its new drug application for anti-cancer Docefrez (Docetaxel) injection.
Cadila Healthcare's joint venture partner Hospira won approval from US FDA for generic version of Sanofi-Aventis' cancer drug Taxotere. CNBC-TV18's Ekta Batra reports on how will this impact Sun Pharma and Cadila Health.